Business

Moderna stock falls 20% as it slashes guidance on low EU sales, tough U.S. vaccine market

Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion. 

adminadmin
Aug 2, 2024 - 06:00
 0  6
Moderna stock falls 20% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion. 
Read More

Tags:

Previous Article

Kohl's bets on Babies R Us as it tries to attract younger families, higher sales

Next Article

UConn basketball's Paige Bueckers to sign NIL deal with Unrivaled league, receiv...

admin
admin

Related Posts

Walmart is laying off, relocating hundreds of corporate workers across the country. Read the memo

Walmart is laying off, relocating hundreds of corporate...

admin May 15, 2024  0  12

Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use

Healthy Returns: Diabetes drug Ozempic may lower dement...

admin Jul 17, 2024  0  5

Clean Energy Ventures raises $305 million to back early-stage climate startups

Clean Energy Ventures raises $305 million to back early...

admin May 30, 2024  0  2